Y. Henkin et al., Dietary treatment of hypercholesterolemia: Do dietitians do it better? A randomized, controlled trial, AM J MED, 109(7), 2000, pp. 549-555
Citations number
38
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
PURPOSE: Current guidelines of the National Cholesterol Education Program (
NCEP) recommend initial dietary counseling by physicians for most patients
with hypercholesterolemia; referral to a registered dietitian and lipid-low
ering drugs are recommended only for patients who remain hypercholesterolem
ic. We evaluated the incremental value of detailed nutritional counseling b
y dietitians when added to general nutritional advice provided by physician
s.
SUBJECTS AND METHODS: Hypercholesterolemic patients detected during a chole
sterol screening project were randomly assigned to receive dietary counseli
ng by a physician only (70 patients) or by a physician and a registered die
titian (66 patients). Patients were observed for 1 year to determine compli
ance with NCEP guidelines.
RESULTS: At 3 months, the mean (+/- SD) decrease in the se rum low-density
lipoprotein (LDL) cholesterol level was 7% +/- 11% in the physician group a
nd 12% +/- 10% in the dietitian group (P <0.004). A decrease of 10% or more
in the LDL cholesterol level was seen in 25 patients (36%) in the physicia
n group and 43 patients (65%) in the dietitian group (P <0.001). Only 40 (2
9%) of the patients in both groups achieved their NCEP target goals at 3 mo
nths. The majority of these were low-risk patients with an LDL cholesterol
target goal of 160 mg/dL. At 12 months, both groups lost about half of the
beneficial effects on LDL cholesterol levels, and the difference between th
e two groups diminished.
CONCLUSIONS: The short-term reduction in LDL cholesterol level, achieved af
ter counseling by dietitians is superior to that achieved by physicians. Ho
wever, long-term compliance remains inadequate. For patients at high risk,
consideration should be given to a more aggressive dietary approach and pos
sibly earlier introduction of lipid-lowering medications. Am J Med. 2000;10
9:549-555. (C) 2000 by Excerpta Medica, Inc.